Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.

Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M.

Cancers (Basel). 2018 Oct 10;10(10). pii: E378. doi: 10.3390/cancers10100378.

2.

Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.

Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI.

Ann Surg. 2016 Mar;263(3):538-45. doi: 10.1097/SLA.0000000000001178. Erratum in: Ann Surg. 2016 May;263(5):e77.

PMID:
25775062
3.

When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.

Liu PH, Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI.

Medicine (Baltimore). 2015 Oct;94(43):e1808. doi: 10.1097/MD.0000000000001808.

4.

[Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].

Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS.

Zhonghua Yi Xue Za Zhi. 2013 Sep 3;93(33):2627-30. Chinese.

PMID:
24360041
5.

Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.

Lee S, Kang TW, Cha DI, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, Kim JM, Kim K.

J Hepatol. 2018 Jul;69(1):70-78. doi: 10.1016/j.jhep.2018.02.026. Epub 2018 Mar 8.

PMID:
29524532
6.
7.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

8.

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.

Xu Y, Shen Q, Wang N, Wu PP, Huang B, Kuang M, Qian GJ.

Chin J Cancer. 2017 Jan 19;36(1):14. doi: 10.1186/s40880-017-0183-x.

9.

Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.

Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Paik YH, Kim MJ, Ahn JH.

Radiology. 2016 Jul;280(1):300-12. doi: 10.1148/radiol.2016151243. Epub 2016 Jan 29.

PMID:
26824711
10.

Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.

Hocquelet A, Aubé C, Rode A, Cartier V, Sutter O, Manichon AF, Boursier J, N'kontchou G, Merle P, Blanc JF, Trillaud H, Seror O.

J Hepatol. 2017 Jan;66(1):67-74. doi: 10.1016/j.jhep.2016.07.010. Epub 2016 Jul 13.

PMID:
27422750
11.

Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.

Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.

J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077.

PMID:
26259976
12.

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.

Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z, Prasoon P, Zeng Y.

J Gastrointest Surg. 2011 Feb;15(2):311-20. doi: 10.1007/s11605-010-1372-y. Epub 2010 Oct 30.

PMID:
21052859
13.

Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.

Yamada S, Utsunomiya T, Morine Y, Imura S, Ikemoto T, Arakawa Y, Kanamoto M, Iwahashi S, Saito Y, Takasu C, Ishikawa D, Shimada M.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S436-42. doi: 10.1245/s10434-014-3575-z. Epub 2014 Feb 25.

PMID:
24566861
14.

Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.

Lee DH, Lee JM, Lee JY, Kim SH, Kim JH, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK, Choi BI.

J Hepatol. 2015 May;62(5):1122-30. doi: 10.1016/j.jhep.2014.12.015. Epub 2014 Dec 18.

PMID:
25529623
15.

Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.

Kim GA, Shim JH, Kim MJ, Kim SY, Won HJ, Shin YM, Kim PN, Kim KH, Lee SG, Lee HC.

Br J Surg. 2016 Jan;103(1):126-35. doi: 10.1002/bjs.9960. Epub 2015 Nov 17.

PMID:
26572697
16.

Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.

Toshimori J, Nouso K, Nakamura S, Wada N, Morimoto Y, Takeuchi Y, Yasunaka T, Kuwaki K, Ohnishi H, Ikeda F, Shiraha H, Takaki A, Yamamoto K.

Acta Med Okayama. 2015;69(4):219-26.

17.

Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

Liu W, Zheng Y, He W, Zou R, Qiu J, Shen J, Yang Z, Zhang Y, Wang C, Wang Y, Zuo D, Li B, Yuan Y.

Aliment Pharmacol Ther. 2018 Sep;48(6):671-681. doi: 10.1111/apt.14929. Epub 2018 Jul 31.

PMID:
30063081
18.

Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.

Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RS, Diniz MA, Alves VA, D'Albuquerque LA, Carrilho FJ.

World J Gastroenterol. 2014 Feb 14;20(6):1585-93. doi: 10.3748/wjg.v20.i6.1585.

19.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276
20.

Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.

Zhang W, Luo E, Gan J, Song X, Bao Z, Zhang H, Chen M.

World J Surg Oncol. 2017 Jul 5;15(1):122. doi: 10.1186/s12957-017-1189-1.

Supplemental Content

Support Center